Last reviewed · How we verify
Multiple-Visit-"Antibiotic Paste"
An antibiotic-containing paste formulation that delivers antimicrobial agents directly to a localized site to eliminate bacterial infection.
An antibiotic-containing paste formulation that delivers antimicrobial agents directly to a localized site to eliminate bacterial infection. Used for Localized bacterial infections requiring multi-visit treatment.
At a glance
| Generic name | Multiple-Visit-"Antibiotic Paste" |
|---|---|
| Also known as | Triple Antibiotic Paste |
| Sponsor | Istanbul Medipol University Hospital |
| Drug class | Topical antibiotic paste |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
This is a topical or intra-canal paste preparation containing antibiotics designed for multiple applications during dental or endodontic treatment. The paste releases antimicrobial agents over time to disinfect the treatment area and reduce bacterial load between visits.
Approved indications
- Intra-canal disinfection in endodontic therapy
- Bacterial infection control in multi-visit dental procedures
Common side effects
- Allergic reaction to antibiotic components
- Tissue irritation or inflammation
- Discoloration of tooth structure
Key clinical trials
- Regenerative Endodontics of Immature Teeth in Multiple Visits Versus Single Visit (NA)
- Single Versus Multiple Visits Endodontic Treatment (PHASE1)
- Postoperative Pain in Single-visit and Multiple-visit Retreatment Cases (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: